Jiménez Rodríguez-Vila M, Hernández Gajate M, Pascual Martín M L, Martín Rojo M, Fernández Alonso M C, Gómez Arranz A, Hernández Pérez P, Martín Rodríguez J F, Orduña Domingo A, Caro-Patón Gómez A
Centro de Salud Casa del Barco, Valladolid.
Aten Primaria. 1992 Jan;9(1):10-2.
To assess the level of immunity in a healthy population to the hepatitis A virus (HAV), according to age groups and in an urban health area.
Transversal random prospective study of a sample of the population found by letters. SITE. Primary Care Centre covering the population of an urban health area in Valladolid.
Random sample of 726 people with an adjustment as to sex and age according to the area's average, in line with the full census of the above area. The sample was 95% trustworthy, with a 3% margin of error. People with serious illness at the time of the study were excluded.
We carried out a social-health count. We established the anti-HAV titer after its detection by enzyme immunoanalysis (HAVAB EIA Abbott); the titers were inferred from the absorbances relating then to that of a a "pool" of serums with very high titers. 69.9% (standardised rate) gave positive. The highest titers were presented in people between 31 and 50 (29.7 +/- 47.0), with significant differences both for lower (17.0 +/- 15.7) and higher (15.7 +/- 19.8) age groups (p. 0.001 for both).
The highest anti-HAV titers corresponded to people in the middle age-group, with a subsequent dropping-off. This could suggest a greater susceptibility to HAV infection in the older person.
根据年龄组评估城市健康区域内健康人群对甲型肝炎病毒(HAV)的免疫水平。
通过信函抽取人群样本进行横向随机前瞻性研究。地点:覆盖巴利亚多利德一个城市健康区域人群的初级保健中心。
随机抽取726人,根据该区域的平均水平按性别和年龄进行调整,与上述区域的全面人口普查一致。样本具有95%的可信度,误差幅度为3%。研究时患有严重疾病的人被排除。
我们进行了社会健康统计。通过酶免疫分析(雅培HAVAB EIA)检测后确定抗HAV滴度;滴度根据当时与高滴度血清“混合样本”吸光度相关的吸光度推断得出。69.9%(标准化率)呈阳性。31至50岁人群的滴度最高(29.7±47.0),与较低年龄组(17.0±15.7)和较高年龄组(15.7±19.8)相比均有显著差异(两者p值均为0.001)。
抗HAV滴度最高的人群为中年组,随后呈下降趋势。这可能表明老年人对HAV感染的易感性更高。